CureVac obtains a patent for its RNA manufacturing process
CureVac, a biopharmaceutical manufacturer specializing in mRNA-based drugs, has obtained a patent from the US…
Monthly Archives: March, 2018
CureVac, a biopharmaceutical manufacturer specializing in mRNA-based drugs, has obtained a patent from the US…